Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
McKinsey
McKesson
Baxter
Johnson and Johnson

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: NEVIRAPINE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NEVIRAPINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Aurobindo NEVIRAPINE nevirapine SUSPENSION;ORAL 077702 ANDA Aurobindo Pharma Limited 65862-057-11 100 mL in 1 BOTTLE (65862-057-11)
Aurobindo NEVIRAPINE nevirapine SUSPENSION;ORAL 077702 ANDA Aurobindo Pharma Limited 65862-057-24 240 mL in 1 BOTTLE (65862-057-24)
Cipla NEVIRAPINE nevirapine SUSPENSION;ORAL 207684 ANDA Cipla USA Inc. 69097-233-44 100 mL in 1 BOTTLE (69097-233-44)
Cipla NEVIRAPINE nevirapine SUSPENSION;ORAL 207684 ANDA Cipla USA Inc. 69097-233-46 240 mL in 1 BOTTLE (69097-233-46)
Boehringer Ingelheim VIRAMUNE nevirapine SUSPENSION;ORAL 020933 NDA Boehringer Ingelheim Pharmaceuticals Inc. 0597-0047-24 1 BOTTLE, PLASTIC in 1 CARTON (0597-0047-24) > 240 mL in 1 BOTTLE, PLASTIC
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Colorcon
Moodys
Merck
AstraZeneca